Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2026-07-27 16:15:04 ET · period of report 2026-07-23 · accession 0001193125-26-318100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-27 16:15 | 2026-07-23 | TCRT | Vieser Jaime | Dir | A - Grant | $1.92 | +8,789 | 47.6K | +23% | +$16.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-23 | A | A | 8,789 | $1.92 | 47,642 | D | — | — | (F1) Represents shares of common stock issued in lieu of board fees. |